DRREDDY Q4 FY26 Earnings Call Transcript & Analysis
PAT (Q4) ₹220 cr; Gross Margin (Q4) 48%; Adjusted PBT (Q4) ₹994 cr. Achieved highest ever annual revenues for FY26.
Read full transcript & analysis
Every earnings call for DRREDDY — management tone, guidance, KPIs and promise tracking, quarter by quarter.
DRREDDY · 5 transcripts · Healthcare · latest Q4 FY26PAT (Q4) ₹220 cr; Gross Margin (Q4) 48%; Adjusted PBT (Q4) ₹994 cr. Achieved highest ever annual revenues for FY26.
Read full transcript & analysisOperating Revenue ₹11,905 cr (+29% YoY); Operating EBITDA ₹1,509 cr (+40% YoY); EBITDA Margin 12.7 percent (+100% YoY). Achieved highest ever quarterly sales in both ICE and EV segments with strong outperformance vs industry.
Read full transcript & analysisConsolidated Revenue ₹8,805 cr (+10% YoY); EBITDA ₹2,351 cr (+3% YoY); EBITDA Margin 26.7% (−174% YoY). Revenue growth of 9.8% YoY to ₹8,805 crores with near double-digit growth.
Read full transcript & analysisEBITDA ₹2,278 cr (+5% YoY); EBITDA Margin 26.7% (−1% YoY); Profit After Tax ₹1,419 cr (+2% YoY). Consolidated revenues grew 11% YoY to ₹8,545 crores ($997 million).
Read full transcript & analysisQ4 Revenue ₹8,506 cr (+20% YoY); Full Year Revenue ₹32,554 cr (+17% YoY); Q4 EBITDA ₹2,475 cr (+32% YoY). Record high revenues exceeding $3.8 billion for full year FY25.
Read full transcript & analysis